Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed on August 7, 2025, and announced on August 8, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,330,960 ordinary shares for cancellation.
- Price Range: Highest price paid was 354.40 pence; lowest was 346.50 pence.
- Volume Weighted Average Price: 351.6198 pence per share.
- Post-Transaction Capital: Registered share capital stands at 8,980,592,548 ordinary shares.
- Treasury Shares: 3,880,205 shares held as treasury shares.
- Voting Shares: 8,976,712,343 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction of outstanding shares due to the cancellation of 1,330,960 shares under the second tranche of the share buyback programme announced on July 31, 2025. This transaction reduces the total number of shares with voting rights.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the buyback programme. The filing includes standard legal disclaimers stating the announcement does not constitute an offer or solicitation of securities. No specific guidance, risks, or contingencies regarding future operations are detailed in this specific report.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updated financial performance metrics not included in this transaction report.